Peri-implant Mucositis Clinical Trial
Official title:
Ozonized In-office and Domiciliary Gels vs Chlorhexidine Gel 1% for the Management of Peri-implant Mucositis Sites: a Randomized Clinical Trial.
This is a split-mouth randomized controlled clinical trial (RCT). After signing the informed consent, patients satisfying the inclusion criteria will undergo supragingival and subgingival professional oral hygiene of both arches performed with ultrasonic instrumentation with PEEK inserts, manual instrumentation with titanium curettes and air polishing with glycine powder. After that, the following treatment will be randomly assigned: - Ozoral Pro and Ozoral gel administration and home application for 2 peri-implant mucositis sites. - Curasept chlorhexidine gel 1% administration and domiciliary application for 14 days for 2 peri-implant contralateral sites. The study will last 6 months. Patients will be visited at: T0, after 1 month from T0 (T1), after 3 months (T2), after 6 months (T3). Professional hygiene will be performed again at T2 and T3. At each recall session, the following periodontal clinical indices were collected using a probe on each peri-implant site: BOP, GBI, conditions of the marginal mucosa (swelling and erythema), suppuration, migration of the marginal mucosa, PD, PI ,BS.
This is a split-mouth randomized controlled clinical trial (RCT). 30 patients is expected to be enrolled. After signing the informed consent, patients satisfying the inclusion criteria will undergo supragingival and subgingival professional oral hygiene of both arches performed with ultrasonic instrumentation with PEEK inserts, manual instrumentation with titanium curettes and air polishing with glycine powder. After that, the following treatment will be randomly assigned: - Ozoral Pro and Ozoral gel administration and home application for 2 peri-implant mucositis sites. - Curasept chlorhexidine gel 1% administration and domiciliary application for 14 days for 2 peri-implant contralateral sites. The study will last 6 months. Patients will be visited at: T0, after 1 month from T0 (T1), after 3 months (T2), and after 6 months (T3). At T2 and T3, professional hygiene will be performed again. At each recall session, the following periodontal clinical indices were collected using a probe on each peri-implant site: BOP (bleeding on probing) and GBI (gingival bleeding index) Conditions of the marginal mucosa (swelling and erythema) Suppuration Migration of the marginal mucosa PD (probing depth) PI (plaque index) BS (bleeding score) ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05332327 -
Comparison of the Accuracy of Different Periodontal Probes for Peri-implant Pocket Registration
|
||
Enrolling by invitation |
NCT06063876 -
Experimental Peri-implant Mucositis on Implant Sites That Were Previously Treated With or Without Implantoplasty
|
N/A | |
Completed |
NCT01941797 -
Experimental Peri-implant Mucositis in Humans
|
N/A | |
Enrolling by invitation |
NCT05675241 -
Characterizing the Inflammation Around Dental Implants
|
||
Completed |
NCT04874467 -
Influence of Keratinized Mucosa on Dental Implants With Mucositis
|
N/A | |
Recruiting |
NCT05906810 -
Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Peri-implantitis and Peri-implant Mucositis
|
N/A | |
Enrolling by invitation |
NCT06137846 -
Treatment of Peri-implant Mucositis and Supportive Peri-implant Therapy
|
N/A | |
Completed |
NCT05945836 -
Peri-implant Disease and Prosthetic Cement: Cross-sectional Study
|
||
Not yet recruiting |
NCT05897736 -
Salivary Minerals in Patients With Peri-implantitis
|
||
Recruiting |
NCT04052373 -
Peri-implantitis Implantoplasty Treatment
|
N/A | |
Completed |
NCT03844035 -
Impacts of Oral Irrigation in Patients With Periimplant Mucositis
|
N/A | |
Completed |
NCT03533166 -
Effects of a 0.03% CHX Mouth Rinse in Peri-implant Mucositis
|
N/A | |
Completed |
NCT03693196 -
The Effect of Different Dental Implant Surface Characteristics on Immunological and Microbiological Parameters
|
N/A | |
Completed |
NCT03421717 -
The Effect of Peri-implant Surgery and Chair-side Supportive Post Surgical Peri-implant Therapy
|
N/A | |
Completed |
NCT03998865 -
Bacterial Microbiota Characterization on Implant-supported PEEK and Titanium Provisional Abutments
|
N/A | |
Recruiting |
NCT05592314 -
Lnfluence of the Prosthetic Emergence Profile on the Prevalence of Peri-implant Diseases: a Cross Sectional Study
|
||
Completed |
NCT04899986 -
Chlorhexidine Gel and Peribioma Periogel Use in Peri-implant Mucositis Sites: a Split-mouth Randomized Clinical Trial.
|
N/A | |
Recruiting |
NCT04415801 -
Effect of Repeated Removal and Re-placement of Abutments Around Dental Implants
|
N/A | |
Recruiting |
NCT04283903 -
Metabolomic and Proteomic Fingerprinting in Peri-implant Diseases
|
||
Completed |
NCT04215432 -
Propolis Extract, Nanovitamin C and Nanovitamin E in Peri-implant Mucositis
|
N/A |